<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Indian J Pharmacol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Indian J Pharmacol</journal-id>
      <journal-id journal-id-type="publisher-id">IJPharm</journal-id>
      <journal-title-group>
        <journal-title>Indian Journal of Pharmacology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0253-7613</issn>
      <issn pub-type="epub">1998-3751</issn>
      <publisher>
        <publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name>
        <publisher-loc>India</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">23112430</article-id>
      <article-id pub-id-type="pmc">3480801</article-id>
      <article-id pub-id-type="publisher-id">IJPharm-44-643</article-id>
      <article-id pub-id-type="doi">10.4103/0253-7613.100403</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Drug Watch</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Fixed drug eruption to fluconazole: A case report and review of literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Pai</surname>
            <given-names>Varadraj V.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
          <xref ref-type="corresp" rid="cor1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bhandari</surname>
            <given-names>Prassanna</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kikkeri</surname>
            <given-names>Naveen Narayanshetty</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Athanikar</surname>
            <given-names>Sharatchandra B.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sori</surname>
            <given-names>Tukaram</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Dermatology, Sri Dharmasthala Manjunatheshwara College of Medical Sciences and Hospital, Sattur, Dharwad, Karnataka, India</aff>
      <aff id="aff2"><label>1</label>Department of Pharmacology, Sri Dharmasthala Manjunatheshwara College of Medical Sciences and Hospital, Sattur, Dharwad, Karnataka, India</aff>
      <author-notes>
        <corresp id="cor1"><bold>Correspondence to:</bold> Dr. Varadraj V. Pai, E-mail: <email xlink:href="docpai@rediffmail.com">docpai@rediffmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Sep-Oct</season>
        <year>2012</year>
      </pub-date>
      <volume>44</volume>
      <issue>5</issue>
      <fpage>643</fpage>
      <lpage>645</lpage>
      <history>
        <date date-type="received">
          <day>08</day>
          <month>2</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>14</day>
          <month>5</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>7</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright: &#xA9; Indian Journal of Pharmacology</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Fixed drug eruption (FDE) is mainly characterized by skin lesions that recur at the same anatomic sites upon repeated exposures to an offending agent. It represents the most common cutaneous adverse drug reaction pattern in Indian patients. Here, we report an FDE to fluconazole.</p>
      </abstract>
      <kwd-group>
        <title>KEY WORDS</title>
        <kwd>Fixed drug eruption</kwd>
        <kwd>cutaneous drug eruption</kwd>
        <kwd>fluconazole</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1-1">
      <title>Introduction</title>
      <p>Cutaneous drug eruption is the most common adverse drug reaction attributed to a drug. Fixed drug eruption (FDE) represents the most common cutaneous adverse drug reaction in Indian patients.[<xref ref-type="bibr" rid="ref1">1</xref>] It is mainly characterized by skin lesions that recur at the same anatomic sites upon repeated exposures to an offending agent.[<xref ref-type="bibr" rid="ref2">2</xref>] The drugs most commonly implicated in FDE are analgesics and antibiotics. We report an FDE occurring secondary to fluconazole intake.</p>
    </sec>
    <sec id="sec1-2">
      <title>Case Report</title>
      <p>A 33-year-old male presented to the skin OPD with a history of rash since one day. The rashes were associated with burning and itching. History of drug intake (tab fluconazole 150 mg) for tinea cruris one day back at 9 pm was followed by itching with rash at 2 am at night. There was a history of similar lesions in the past due to some medication for a similar dermatological complaint. There was no history of fever or any medications. On cutaneous examination, well-defined erythematous plaques of varied sizes were present over the chest, back, lower limbs, and lips [<xref ref-type="fig" rid="F1">Figure 1</xref>]. The largest over the chest was 10X10 cm. No involvement of the genitalia was present. A patch test done with the offending drug was positive. Complete blood count and biochemical investigations were normal. The causality assessment was carried out using the Naranjo ADR probability scale or WHO-UMC causality assessment scale [Tables <xref ref-type="table" rid="T1">1</xref> and <xref ref-type="table" rid="T2">2</xref>]. A diagnosis of FDE to fluconazole was made and the patient was told to stop the offending agent and was started on oral antihistamines and topical steroids with complete recovery in five days.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Violaceous plaque with erythematous border over the lower limb</p>
        </caption>
        <graphic xlink:href="IJPharm-44-643-g001"/>
      </fig>
      <table-wrap id="T1" position="float">
        <label>Table 1</label>
        <caption>
          <p>Naranjo ADR probability scale</p>
        </caption>
        <graphic xlink:href="IJPharm-44-643-g002"/>
      </table-wrap>
      <table-wrap id="T2" position="float">
        <label>Table 2</label>
        <caption>
          <p>WHO-UMC causality assessment system</p>
        </caption>
        <graphic xlink:href="IJPharm-44-643-g003"/>
      </table-wrap>
    </sec>
    <sec sec-type="discussion" id="sec1-3">
      <title>Discussion</title>
      <p>FDE is a distinctive drug-induced dermatosis with a characteristic recurrence at the same sites of the skin or mucous membrane after repeated administration of the causative drug.[<xref ref-type="bibr" rid="ref2">2</xref>] It was first described by Bourns in1889; five years later, it was termed by Brocq as &#x201C;eruption erythemato-pigmentee fixe&#x201D;.[<xref ref-type="bibr" rid="ref3">3</xref>] FDE represents the most common cutaneous adverse drug reaction in the Indian scenario.[<xref ref-type="bibr" rid="ref1">1</xref>] This adverse drug reaction seems to be more common in this part of the world, probably reflecting a predisposing genetic background.[<xref ref-type="bibr" rid="ref4">4</xref>] FDE is believed to be a lymphocyte CD8-mediated reaction, wherein the offending drug may induce local reactivation of memory T cell lymphocytes localized in epidermal and dermal tissues and targeted initially by the viral infection.[<xref ref-type="bibr" rid="ref5">5</xref>] The most common drugs causing FDE are antibiotics (trimethoprim-sulfamethoxazole, tetracycline, penicillin, and erythromycin), followed by nonsteroidal anti-inflammatory drugs (NSAIDs; diclofenac sodium, aspirin, naproxen, and ibuprofen).[<xref ref-type="bibr" rid="ref2">2</xref>]</p>
      <p>FDE characteristically recurs in the same site or sites each time the drug is administered, and the number of sites may increase with subsequent exposure.[<xref ref-type="bibr" rid="ref2">2</xref>] FDE presents mainly as sharply marginated, round or oval itchy plaques of erythema and edema becoming dusky violaceous or brown, and sometimes vesicular or bullous.[<xref ref-type="bibr" rid="ref2">2</xref>] Most of the reactions occur within 30 minutes to one day of drug exposure.[<xref ref-type="bibr" rid="ref2">2</xref><xref ref-type="bibr" rid="ref4">4</xref>] The lesions may be solitary or multiple. The most common sites are the genitalia in males and the extremities in females.[<xref ref-type="bibr" rid="ref4">4</xref>] Lesions can also be seen on the perianal, periorbital, and trunk.[<xref ref-type="bibr" rid="ref2">2</xref>] They may be bullous, pigmented, or nonpigmented. Pigmented lesions can be seen in pigmented individuals and heroin addicts. Nonpigmented lesions are reported with pseudoephedrine use.[<xref ref-type="bibr" rid="ref6">6</xref>]</p>
      <p>Histologically, FDE is characterized by marked basal cell hydropic degeneration with pigmentary incontinence. Scattered keratinocyte necrosis with eosinophilic cytoplasm and pyknotic nucleus (civatte bodies) are seen in the epidermis. Infiltration of lymphocytes, histiocytes, and neutrophil polymorphs is evident in the upper dermis.[<xref ref-type="bibr" rid="ref7">7</xref>]</p>
      <p>As most case reports concern suspected adverse drug reactions, pharmacovigilance can be problematic. Also, adverse reactions are rarely specific for the drug without specific diagnostic tests and a rechallenge is rarely ethically justified.[<xref ref-type="bibr" rid="ref8">8</xref>] Therefore, certain causality assessment scales regarding drug reaction have been described like the Naranjo ADR probability scale or the WHO-UMC causality assessment system.[<xref ref-type="bibr" rid="ref8">8</xref><xref ref-type="bibr" rid="ref9">9</xref>] In our case, the association was &#x2018;definite&#x2019; and &#x2018;certain&#x2019; as per the Naranjo scale and WHO-UMC causality assessment system, respectively. For nonimmediate drug reactions like FDE, patch tests, together with delayed-reading intradermal tests, lymphocyte transformation tests (LTTs), and oral challenges can be used in selective cases.[<xref ref-type="bibr" rid="ref10">10</xref>] Treatment includes stopping the offending drug with topical steroids, emollients, and oral antihistamines.[<xref ref-type="bibr" rid="ref2">2</xref>]</p>
      <p>Fluconazole is one of the most common drugs used in dermatology practice. It is a triazole which acts on lanosterol 14 &#x3B1;-demethylase and inhibits the conversion of lanosterol to ergosterol.[<xref ref-type="bibr" rid="ref11">11</xref>] The adverse effects most frequently reported are nausea, headache, vomiting, and self-limiting biliary hepatitis.[<xref ref-type="bibr" rid="ref11">11</xref>] The most common cutaneous adverse effect is skin rash. Severe cutaneous reactions like Stevens Johnson syndrome, acute generalized exanthematous pustulosis, toxic epidermal necrolysis, and erythema multiforme have been reported.[<xref ref-type="bibr" rid="ref12">12</xref>] FDE to fluconazole is very rarely reported, with 13 cases reported till date.[<xref ref-type="bibr" rid="ref13">13</xref><xref ref-type="bibr" rid="ref14">14</xref>] Cross-reactions may occur with structurally related agents, such as itraconazole.[<xref ref-type="bibr" rid="ref15">15</xref>]</p>
      <p>Therefore, this case is presented for its rarity and also to create awareness about the various side effects associated with this very commonly prescribed medication.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p><bold>Source of Support:</bold> Nil</p>
      </fn>
      <fn fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> No.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patel</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Marfatia</surname>
              <given-names>YS</given-names>
            </name>
          </person-group>
          <article-title>Clinical study of cutaneous drug eruptions in 200 patients</article-title>
          <source>Indian J Dermatol Venerol Leprol</source>
          <year>2008</year>
          <volume>74</volume>
          <fpage>430</fpage>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Breathnach</surname>
              <given-names>SM</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Burns</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Breathnach</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cox</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Griffiths</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Drug reactions</article-title>
          <source>Rook's Textbook of Dermatology</source>
          <year>2010</year>
          <edition>8th ed</edition>
          <publisher-loc>Oxford</publisher-loc>
          <publisher-name>Blackwell Science</publisher-name>
          <fpage>28</fpage>
          <lpage>177</lpage>
        </element-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brocq</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>&#xC9;ruptionerythemato-pigment&#xE9;e fixe due al&#x2019;antipyrine</article-title>
          <source>Ann Dermatol Venereol</source>
          <year>1894</year>
          <volume>5</volume>
          <fpage>308</fpage>
          <lpage>13</lpage>
        </element-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brahimi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Routier</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Raison-Peyron</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Tronquoy</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Pouget-Jasson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Amarger</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A three-year-analysis of fixed drug eruptions in hospital settings in France</article-title>
          <source>Eur J Dermatol</source>
          <year>2010</year>
          <volume>20</volume>
          <fpage>461</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="pmid">20507840</pub-id>
        </element-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shiohara</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mizukawa</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Fixed drug eruption: A disease mediated by self-inflicted responses of intraepidermal T cells</article-title>
          <source>Eur J Dermatol</source>
          <year>2007</year>
          <volume>17</volume>
          <fpage>201</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">17478380</pub-id>
        </element-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hindioglu</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Sahin</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Nonpigmenting solitary fixed drug eruption caused bypseudoephedrine hydrochloride</article-title>
          <source>J Am Acad Dermatol</source>
          <year>1998</year>
          <volume>38</volume>
          <fpage>499</fpage>
          <lpage>500</lpage>
          <pub-id pub-id-type="pmid">9520039</pub-id>
        </element-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Hiatt</surname>
              <given-names>KM</given-names>
            </name>
            <name>
              <surname>Horn</surname>
              <given-names>TD</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Elder</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Elenitsas</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>BL</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous toxicities of drugs</article-title>
          <source>Levers histopathology of the skin</source>
          <year>2009</year>
          <edition>10th ed</edition>
          <publisher-loc>New Delhi</publisher-loc>
          <publisher-name>Lippincott Williams and Wilkins</publisher-name>
          <fpage>311</fpage>
          <lpage>31</lpage>
        </element-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <element-citation publication-type="webpage">
          <article-title>The use of the WHO&#x2013;UMC system for standardised case causality assessment</article-title>
          <date-in-citation>Last accessed on 2012 May 12</date-in-citation>
          <comment>Available from:
<uri xlink:type="simple" xlink:href="http://www.who-umc.org/graphics/24734.pdf">http://www.who-umc.org/graphics/24734.pdf</uri></comment>
        </element-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naranjo</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Busto</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Sellers</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Sandor</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ruiz</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Roberts</surname>
              <given-names>EA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A method for estimating the probability of adverse drug reactions</article-title>
          <source>Clin Pharmacol Ther</source>
          <year>1981</year>
          <volume>30</volume>
          <fpage>239</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">7249508</pub-id>
        </element-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Romano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Viola</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gaeta</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rumi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Maggioletti</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Patch testing in non-immediate drug eruptions</article-title>
          <source>Allergy Asthma Clin Immunol</source>
          <year>2008</year>
          <volume>4</volume>
          <fpage>66</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="pmid">20525127</pub-id>
        </element-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Phillips</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <person-group person-group-type="editor">
            <name>
              <surname>Wolverton</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>Topical antifungal agents</article-title>
          <source>Comprehensive dermatologic drug therapy</source>
          <year>2007</year>
          <edition>2nd ed</edition>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Elsevier</publisher-name>
          <fpage>75</fpage>
          <lpage>95</lpage>
        </element-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Az&#xF3;n-Masoliver</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vilaplana</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Fluconazole-induced toxic epidermal necrolysis in a patient with human immunodeficiency virus infection</article-title>
          <source>Dermatology</source>
          <year>1993</year>
          <volume>187</volume>
          <fpage>268</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">8274783</pub-id>
        </element-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morgan</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Carmichael</surname>
              <given-names>AJ</given-names>
            </name>
          </person-group>
          <article-title>Fixed drug eruption with fluconazole</article-title>
          <source>BMJ</source>
          <year>1994</year>
          <volume>308</volume>
          <fpage>454</fpage>
          <pub-id pub-id-type="pmid">8124179</pub-id>
        </element-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beecker</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Colantonio</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Fixed drug eruption due to fluconazole</article-title>
          <source>CMAJ</source>
          <year>2012</year>
          <volume>184</volume>
          <fpage>675</fpage>
          <pub-id pub-id-type="pmid">22231677</pub-id>
        </element-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gupta</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Thami</surname>
              <given-names>GP</given-names>
            </name>
          </person-group>
          <article-title>Fixed drug eruption caused by itraconazole: Reactivity and cross reactivity</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2008</year>
          <volume>58</volume>
          <fpage>521</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">18280361</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
